摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-氟-2-硝基苯基)乙酮 | 1214346-44-7

中文名称
1-(4-氟-2-硝基苯基)乙酮
中文别名
——
英文名称
1-(4-fluoro-2-nitrophenyl)ethan-1-one
英文别名
1-(4-fluoro-2-nitrophenyl)ethanone
1-(4-氟-2-硝基苯基)乙酮化学式
CAS
1214346-44-7
化学式
C8H6FNO3
mdl
MFCD13194367
分子量
183.139
InChiKey
FWVAEFFNYPYLFH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-氟-2-硝基苯基)乙酮铁粉氯化铵 作用下, 以 乙醇 为溶剂, 以98%的产率得到2'-氨基-4'-氟苯乙酮
    参考文献:
    名称:
    Discovery of a novel series of 4-quinolone JNK inhibitors
    摘要:
    A novel series of highly selective JNK inhibitors based on the 4-quinolone scaffold was designed and synthesized. Structure based drug design was utilized to guide the compound design as well as improvements in the physicochemical properties of the series. Compound (13c) has an IC50 of 62/170 nM for JNK1/2, excellent kinase selectivity and impressive efficacy in a rodent asthma model. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2012.10.066
  • 作为产物:
    描述:
    4-氟苯乙酮吡啶盐酸 、 dipotassium peroxodisulfate 、 silver(I) nitrite 、 palladium diacetate 作用下, 以 甲醇乙醚1,2-二氯乙烷 为溶剂, 反应 72.0h, 生成 1-(4-氟-2-硝基苯基)乙酮
    参考文献:
    名称:
    硝基化合物的特异合成通过钯催化氮给体定向族C ?H硝化
    摘要:
    的N-杂芳族化合物的硝化:钯催化的直接的第一个例子邻芳基C的-nitration  H键进行说明。一系列氮杂芳烃,例如2-芳基喹喔啉,吡啶,吡唑和O-甲基肟被硝化,具有出色的化学和区域选择性(参见方案; DCE = 1,2-二氯乙烷)。初步的机理研究支持在氧化条件下涉及钯(II / III)和/或钯(II / IV)催化循环的银介导的自由基机理。
    DOI:
    10.1002/chem.201002581
点击查看最新优质反应信息

文献信息

  • Base-Mediated [3 + 4]-Cycloaddition of Anthranils with Azaoxyallyl Cations: A New Approach to Multisubstituted Benzodiazepines
    作者:Juan Feng、Meng Zhou、Xuanzi Lin、An Lu、Xiaoyi Zhang、Ming Zhao
    DOI:10.1021/acs.orglett.9b02118
    日期:2019.8.16
    A new [3 + 4] cycloaddition of azaoxyallyl cations and anthranils has been achieved for rapid access to multisubstituted benzodiazepine derivatives. A variety of anthranils and α-halo hydroxamates were both effective substrates with simple operations under transition-metal-free conditions. The intriguing features of this method include its mild nature of the reaction conditions, high efficiency, broad
    为了快速获得多取代的苯并二氮杂衍生物,已经实现了新的[3 + 4]氮杂烯丙基阳离子和蒽基的环加成反应。多种蒽类和α-卤代异羟肟酸酯都是有效的底物,在无过渡金属的条件下操作简单。该方法的引人入胜的特征包括其反应条件温和的性质,高效率,广泛的底物范围和广泛的官能团相容性。
  • Palladium-Catalyzed Chelation-Assisted Aromatic C–H Nitration: Regiospecific Synthesis of Nitroarenes Free from the Effect of the Orientation Rules
    作者:Wei Zhang、Shaojie Lou、Yunkui Liu、Zhenyuan Xu
    DOI:10.1021/jo400594j
    日期:2013.6.21
    ortho-nitration of aryl C–H bond is described. A range of azaarenes such as 2-arylquinoxalines, pyridines, quinoline, and pyrazoles were nitrated with excellent chemo- and regioselectivity. Using the O-methyl oximyl group as a removable directing group, the regiospecific synthesis of a variety of o-nitro aryl ketones was achieved starting from aryl ketones via a three-step process involving the Pd-catalyzed
    描述了钯催化的螯合辅助芳基CH键的邻位硝化反应。一系列氮杂芳烃(例如2-芳基喹喔啉,吡啶,喹啉和吡唑)被硝化,具有出色的化学和区域选择性。使用ø -甲基肟基团为一个可移动定向基团,各种的区域专一性合成ø硝基芳基酮经由涉及三个步骤的方法来实现从开始芳基酮Pd催化的本位C-H键的-nitration作为关键步骤。机理研究支持在氧化条件下涉及Pd((II / III)和/或Pd(II / IV)催化循环的银介导的自由基机理。
  • [EN] HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET AGENTS D'IMAGERIE POUR L'IMAGERIE DE LA PROTÉINE HUNTINGTINE
    申请人:CHDI FOUNDATION INC
    公开号:WO2021252775A1
    公开(公告)日:2021-12-16
    Provided herein are certain compounds and imaging agents useful for detecting a disease or condition associated with protein aggregation, especially huntingtin protein aggregation, compositions thereof, and methods of their use.
    本文提供了用于检测与蛋白聚集相关的疾病或病况,特别是与亨廷顿蛋白聚集相关的某些化合物和成像剂,以及它们的组合物和使用方法。
  • Synthesis, molecular modeling and biological evaluation of aza-flavanones as α-glucosidase inhibitors
    作者:Sivaprasad Kasturi、Sujatha Surarapu、Chandra Chary Bathoju、Srinivas Uppalanchi、Shubham Dwivedi、Yogeeswari Perumal、Dilep Kumar Sigalapalli、Bathini Nagendra Babu、Krishna S. Ethiraj、Jaya Shree Anireddy
    DOI:10.1039/c7md00162b
    日期:——
    has been employed to synthesize a variety of aza-flavanones and their α-glucosidase inhibitory activity is evaluated using acarbose, miglitol and voglibose as reference standards. Molecular modeling studies were performed for all compounds to identify the important binding modes responsible for the inhibition activity of α-glucosidase which helped find key interactions between the enzyme and the active
    已经使用一种有效的酸催化方法来合成多种氮杂黄酮,并使用阿卡波糖,米格列醇和伏格列波糖作为参考标准评估了它们对α-葡萄糖苷酶的抑制活性。对所有化合物进行了分子建模研究,以鉴定负责α-葡萄糖苷酶抑制活性的重要结合模式,这有助于发现酶与活性化合物之间的关键相互作用。在所有化合物中,与标准参考药物相比,化合物5g,5r和5w表现出较高的α-葡萄糖苷酶抑制活性,并被确定为有前途的潜在抗糖尿病药。这项研究是对氮杂黄酮作为α-葡萄糖苷酶抑制剂的首次生物学评估。
  • [EN] HER2 MUTATION INHIBITORS<br/>[FR] INHIBITEURS DE MUTATION HER2
    申请人:ARRAY BIOPHARMA INC
    公开号:WO2022003575A1
    公开(公告)日:2022-01-06
    This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
    本发明涉及式(I)的化合物及其对映体,以及式(I)及其对映体的药用可接受盐,其中L1、L2、R1、R2、R3和n如本文所定义。本发明还涉及包括这些化合物和盐的药物组合物,以及利用这些化合物、盐和组合物治疗需要的受试者中的异常细胞生长,包括癌症的方法和用途。
查看更多